文献速递湿疹皮炎与荨麻疹

TMEM232通过核因子-κB与信号转导及转录激活因子3信号通路促进特应性皮炎炎症反应

TMEM232 promotes the inflammatory response in atopic dermatitis via the nuclear factor-κB and signal transducer and activator of transcription 3 signalling pathways.
PubMed 文献 · Br J Dermatol · 2023-01-01

该研究探讨跨膜蛋白232(TMEM232)在特应性皮炎(AD)中的作用与机制。结果显示AD患者皮损、MC903诱导AD小鼠模型及炎症因子刺激的角质形成细胞中TMEM232表达显著升高;Tmem232-/-小鼠在MC903作用下皮炎严重度、背部肥大细胞浸润及Th1/Th2相关炎症因子表达显著降低。TMEM232通过激活核因子-κB和STAT3通路加剧炎症,并受白细胞介素-4/STAT6轴调控形成自我放大环路;局部应用Tmem232 siRNA可明显改善AD模型皮损。

要点

  • AD患者皮损及AD模型、炎症因子刺激的角质形成细胞中TMEM232表达显著升高。
  • MC903作用下Tmem232-/-小鼠皮炎严重度、背部肥大细胞浸润及Th1/Th2相关炎症因子表达较野生型显著降低。
  • 局部应用Tmem232 siRNA可明显改善AD模型皮损。

核心结论

  • 本研究首次阐述TMEM232的功能,其参与调控AD炎症,可能成为AD治疗的潜在靶点。

研究设计与样本

  • 研究检测AD患者皮损、MC903诱导AD小鼠模型、人原代角质形成细胞及不同炎症因子刺激的永生化人角质形成细胞系(HaCaT)中TMEM232表达。
  • 在HaCaT细胞和Tmem232敲除(Tmem232-/-)小鼠中分析TMEM232在AD中的作用。
  • 使用Tmem232特异性小干扰RNA(siRNA)在AD小鼠模型中评估其治疗潜力。

主要发现

  • 与对照相比,AD患者皮损、MC903诱导AD小鼠模型及不同炎症因子刺激的人原代角质形成细胞和HaCaT细胞中TMEM232表达显著升高。
  • 在MC903存在下,Tmem232-/-小鼠较野生型小鼠皮炎严重度、背部肥大细胞浸润及皮肤组织中Th1和Th2相关炎症因子表达显著降低。
  • 体外和体内实验进一步显示,AD中TMEM232上调通过激活核因子-κB和STAT3通路加剧炎症反应,并受白细胞介素-4/STAT6轴调控,形成自我放大环路。
  • 局部应用Tmem232 siRNA可明显改善AD模型中的AD样皮损。

临床怎么用

  • 作者认为TMEM232可能成为AD治疗的潜在靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Our group previously found that the transmembrane protein 232 (TMEM232) gene was associated with atopic dermatitis (AD) by genome-wide association study and fine mapping study. However, its function is unclear so far. OBJECTIVES: To investigate the roles and mechanisms of TMEM232 in AD. METHODS: The expression of TMEM232 was investigated in skin lesions of patients with AD, the MC903-induced AD mouse model, human primary keratinocytes and immortalized human keratinocyte cell line (HaCaT) cells stimulated with different inflammatory factors. The role of TMEM232 in AD was analysed in HaCaT cells and Tmem232 knockout (Tmem232-/-) mice. Tmem232-specific small interfering RNA (siRNA) was used to evaluate its therapeutic potential in the AD mouse model. RESULTS: The expression of TMEM232 was significantly increased in skin lesions of patients with AD, the MC903-induced AD mouse model and human primary keratinocytes and HaCaT cells stimulated with different inflammatory factors compared with controls. In the presence of MC903, Tmem232-/- mice exhibited significantly reduced dermatitis severity, mast-cell infiltration in the back, and expression of T-helper (Th)1 and Th2-related inflammatory factors in skin tissue compared with wild-type mice. In vitro and in vivo experiments further showed that upregulation of TMEM232 in AD exacerbated the inflammation response through activating the pathway of nuclear factor-κB and signal transducer and activator of transcription (STAT) 3, and was regulated by the interleukin-4/STAT6 axis, which formed a self-amplifying loop. Finally, topical application of Tmem232 siRNA markedly ameliorated AD-like lesions in the AD model. CONCLUSIONS: This study is the first to outline the function of TMEM232. It is involved in regulating inflammation in AD and may be a potential target for AD treatment.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Han J, Cai X, Qin S, et al. TMEM232 promotes the inflammatory response in atopic dermatitis via the nuclear factor-κB and signal transducer and activator of transcription 3 signalling pathways. Br J Dermatol. 2023. PMID: 36928730. doi:10.1093/bjd/ljad078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。